Nuveen, LLC Keros Therapeutics, Inc. Put Options Transaction History
Nuveen, LLC
- $348 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding KROS
# of Institutions
179Shares Held
32.8MCall Options Held
938KPut Options Held
1.39M-
Vanguard Group Inc Valley Forge, PA2.63MShares$36.1 Million0.0% of portfolio
-
Jpmorgan Chase & CO New York, NY2.6MShares$35.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.51MShares$34.5 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA2MShares$27.4 Million3.97% of portfolio
-
Morgan Stanley New York, NY1.7MShares$23.3 Million0.0% of portfolio
About Keros Therapeutics, Inc.
- Ticker KROS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,757,000
- Market Cap $353M
- Description
- Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...